| Literature DB >> 33310051 |
Snehal Nirgude1, Bibha Choudhary2.
Abstract
Glutathione peroxidases are well known antioxidant enzymes. They catalyze the reduction of hydrogen peroxide or organic hydroperoxides using glutathione. Among the reported 8 GPxs, GPx3, a highly conserved protein and a major ROS scavenger in plasma, has been well studied and confirmed to play a vital role as a tumor suppressor in most cancers. Additionally, this gene is known to be epigenetically regulated. It is downregulated either by hypermethylation or genomic deletion. In this review, we summarized the role of GPX3 in various cancers, its use as a prognostic biomarker, and a potential target for clinical intervention.Entities:
Keywords: Biomarker; Glutathione peroxidase; Hypermethylation; Therapeutic
Mesh:
Substances:
Year: 2020 PMID: 33310051 DOI: 10.1016/j.bcp.2020.114365
Source DB: PubMed Journal: Biochem Pharmacol ISSN: 0006-2952 Impact factor: 5.858